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TIF1α
TIF1γThe adenovirus E4-ORF3 protein promotes viral replication by relocalizing cellular proteins into nuclear track
structures, interfering with potential anti-viral activities. E4-ORF3 targets transcriptional intermediary factor 1
alpha (TIF1α), but not homologous TIF1β. Here, we introduce TIF1γ as a novel E4-ORF3-interacting partner.
E4-ORF3 relocalizes endogenous TIF1γ in virus-infected cells in vivo and binds to TIF1γ in vitro.We used the ho-
mologous nature, yet differing binding capabilities, of these proteins to study how E4-ORF3 targets proteins for
track localization. We mapped the ability of E4-ORF3 to interact with speciﬁc TIF1 subdomains, demonstrating
that E4-ORF3 interacts with the Coiled-Coil domains of TIF1α, TIF1β, and TIF1γ, and that the C-terminal half of
TIF1β interferes with this interaction. The results of E4-ORF3-directed TIF1 protein relocalization assays per-
formed in vivo were veriﬁed using coimmunoprecipitation assays in vitro. These results suggest that E4-ORF3
targets proteins for relocalization through a loosely homologous sequence dependent on accessibility.
© 2011 Elsevier Inc. All rights reserved.Introduction
The adenovirus (Ad) early region 4 (E4) plays an essential role in pro-
moting a successful virus replication cycle. Loss of the entire E4 region
leads to defects in viral DNA replication as well as a reduction in infec-
tious particle production (Halbert et al., 1985; Weinberg and Ketner,
1986). In addition, protein products of the E4 region are required
for effective shutoff of host cell protein synthesis, late viral mRNA accu-
mulation, and late protein synthesis (Halbert et al., 1985; Weinberg
and Ketner, 1986). Of the six known E4 protein products, reintroduction
of either the E4-ORF6 or the E4-ORF3 protein is sufﬁcient to restore virus
growth properties to near wild type levels (Bridge and Ketner, 1989;
Huang and Hearing, 1989).
Together with the Ad E1B-55K protein, the E4-ORF6 protein func-
tions as an adaptor molecule in an E3 cullin-RING ligase complex
(Harada et al., 2002; Querido et al., 2001), promoting the ubiquitina-
tion and proteosome-dependent degradation of substrates such as
p53 (Harada et al., 2002; Querido et al., 2001), Mre11-Rad50-Nbs1
(MRN) complex proteins (Stracker et al., 2002), DNA ligase IV
(Baker et al., 2007), integrinα3 (Dallaire et al., 2009), and bloom heli-
case (Orazio et al., 2010). In addition to targeting known substrate
proteins, the E4-ORF6 and E1B-55K ubiquitin ligase complex also fa-
cilitates the nuclear export of viral mRNA (Blanchette et al., 2008;ring).
rights reserved.Woo and Berk, 2007). Independent of the E1B-55K interaction, the
E4-ORF6 protein is able to bind p53, blocking its downstream tran-
scriptional activities (Dobner et al., 1996).
The E4-ORF3 and E4-ORF6 proteins inhibit an overlapping, but
non-identical, pool of target cellular proteins. Rather than targeting
proteins for degradation, E4-ORF3 promotes a productive infection
by recruiting cellular proteins into elongated nuclear track structures,
inhibiting their anti-viral properties. This is evident in the disparate
mechanisms by which both E4-ORF3 and E4-ORF6 target the MRN
DNA repair complex. In response to infection by Ad lacking the E4 re-
gion, the MRN complex associates with virus replication centers and
activates a DNA damage response (DDR) (Carson et al., 2009; Karen
et al., 2009; Stracker et al., 2002). Ultimately, the DDR severely inhibits
viral DNA replication and triggers the formation of viral genomic muti-
mers termed concatamers (Stracker et al., 2002). Disruption of theMRN
complex, through E4-ORF6-dependent degradation or recruitment into
E4-ORF3-containing nuclear tracks is sufﬁcient to rescue this replication
defect (Evans and Hearing, 2005; Lakdawala et al., 2008; Mathew and
Bridge, 2008). Like E4-ORF6, E4-ORF3 also targets p53. Acting upon
p53 indirectly, E4-ORF3 down-regulates p53 target gene expression
by promoting the formation of heterochromatin at p53 target promoter
regions (Soria et al., 2010). E4-ORF3 also can impede the host cell,
interferon-mediated antiviral response by sequestering PML, the nucle-
ating factor in PML nuclear bodies (Ullman and Hearing, 2008; Ullman
et al., 2007). Recently, we have shown that E4-ORF3 targets TIF1α, a
protein implicated in several nuclear hormone receptor signaling
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icance of this interaction remains unknown, the ability of E4-ORF3 to
relocalize TIF1α is conserved across multiple Ad serotypes (Yondola
and Hearing, 2007).
TIF1α belongs to the transcriptional intermediary factor 1 (TIF1)
family of proteins, consisting of four known members in humans–
TIF1α, TIF1β, TIF1γ, and TIF1δ–as well as drosophila, murine, and
zebraﬁsh orthologs. Acting as coregulators of gene expression, TIF1
family proteins inﬂuence a wide array of gene expression pathways.
Inﬂuencing the RA signaling pathway, TIF1α responds to RA by asso-
ciating with nuclear receptors at the retinoic acid response element
(RARE), where it regulates gene expression and ultimately promotes
growth suppression (Khetchoumian et al., 2007; Zhong et al., 1999).
Implicated as a tumor suppressor protein, loss of TIF1α leads to an in-
crease in hepatic tumors in null mice (Khetchoumian et al., 2007).
Furthermore, TIF1α has been shown to promote p53 ubiquitination,
leading to its proteosome-dependent degradation (Allton et al.,
2009). TIF1β acts as a corepressor of gene expression. Associating
with promoter regions through interactions with DNA-bound KRAB
domain containing proteins, TIF1β recruits chromatin modiﬁers
such as HP1 family proteins to facilitate chromatin remodeling and
transcriptional silencing (Ryan et al., 1999; Sripathy et al., 2006). Act-
ing in the TGFβ signaling pathway, TIF1γ plays a key role in ectoderm
production in Xenopus (Dupont et al., 2005, 2009), as well as ery-
throid production in humans (He et al., 2006). Recent evidence suggests
a role for TIF1γ in promoting zebraﬁsh erythroid development as part of
a Pol II containing transcription complex (Bai et al., 2010; Ransom et al.,
2004). Furthermore, the loss of TIF1γ has been implicated in the devel-
opment of pancreatic cancer (Vincent et al., 2009). TIF1δ acts as a testis-
speciﬁc transcriptional corepressor that can interact with chromatin
modiﬁer HP1γ (Khetchoumian et al., 2004).
TIF1 family proteins fall into the greater tripartite motif (TRIM)
protein family. Characterized by an N-terminal RBCC motif, TRIM
family proteins contain three domains of conserved order and spac-
ing: a RING ﬁnger, one or two B-boxes, and a Coiled-Coil domain.
Binding two zinc atoms in a cross brace motif, the RING ﬁnger domain
is often associated with E3 ubiquitin ligase activity (reviewed in
Meroni and Diez-Roux, 2005). Suggested to possess a similar quater-
nary structure as the RING domain (Tao et al., 2008), the B-box do-
main also coordinates zinc atoms. Two forms of this motif exist, B1
and B2, with differing patterns of histidine and cysteine residues critical
for zinc coordination. TIF1 family proteins contain tandem B1 and B2
domains. The Coiled-Coil motif often mediates homomultimer forma-
tion and consists of a series of 1 to 3 amphipathic coiled subdomains
(Peng et al., 2000, 2002; Reymond et al., 2001). TRIM family proteins
contain the greatest sequence diversity in their C-terminal half, but
often contain one ormultiple C-terminal conserved protein foldingmo-
tifs. TIF1 family proteins all contain C-terminal PHD/bromo domains.
We have previously demonstrated that E4-ORF3 targets TIF1α, but
not the related TIF1β protein, for nuclear track localization in a man-
ner dependent on the N-terminal RBCC motif (Yondola and Hearing,
2007). In this paper, we introduce TIF1γ as a novel E4-ORF3 track
colocalizing protein and further characterize the ability of E4-ORF3
to target cellular proteins. We wished to determine which speciﬁc
TIF1 protein sequences are sufﬁcient for E4-ORF3-directed relocaliza-
tion and how E4-ORF3 selectively targets TIF1α and TIF1γ without
affecting TIF1β. Taking advantage of the homologous nature, yet differ-
ing recruitment capabilities of these proteins, we generated a series of
EYFP-fusion constructs to map the ability of speciﬁc TIF1 subdomains
to interact with E4-ORF3 under varying protein contexts. Using a series
of isolated TIF1 protein segments, we demonstrate that E4-ORF3 associ-
ates with the Coiled-Coil domains of TIF1α, TIF1β, and TIF1γ. Further-
more, we generated a series of TIF1α/β and TIF1γ/β chimeric proteins
whose localization patterns imply that the presence of the C-terminal
portion of TIF1β interferes with this interaction. These results sug-
gest that E4-ORF3 targets TIF1 family members through a looselyhomologous sequence and that the accessibility of this sequence inﬂu-
ences the ability of E4-ORF3 to recruit these proteins into nuclear tracks.
Results
E4-ORF3 relocalizes TIF1γ in vivo and binds TIF1γ in vitro
In order to examine if the E4-ORF3 protein alters the localization
of endogenous TIF1γ in vivo, indirect immunoﬂuorescence analyses
were performed (Fig. 1). In uninfected HeLa cells, TIF1γ staining
appeared generally uniform throughout the nucleus with some un-
derlying foci (Fig. 1A). The TIF1γ-containing foci were found to colo-
calize with PML nuclear bodies (Figs. 1B, C; arrows). Six hours after
infection with wild-type Ad5, the TIF1γ protein was relocalized into
nuclear track structures (Fig. 1D) that colocalized with E4-ORF3
(Figs. 1E, F), although not all TIF1γ was reorganized at this early
time point during infection. TIF1γ relocalization was more complete
at early times after infection when a higher multiplicity of infection
was used (Fig. 1G) indicating that the E4-ORF3 protein may be limit-
ing. This reorganization of TIF1γ during Ad infection required the E4-
ORF3 protein since no change in TIF1γ localization was evident in cells
infected with an E4-ORF3mutant virus (Fig. 1H; infected cells identiﬁed
using an antibody against theAdDNAbindingprotein, DBP, Figs. 1I, J). At
late times after infection with wild-type Ad5, TIF1γ reorganization into
E4-ORF3-containing tracks was nearly complete (Figs. 1K–M). We next
examined if the E4-ORF3 protein binds to TIF1γ in vitro using a coimmu-
noprecipitation assay. HeLa cells were infected with Ad E1-replacement
vectors that constitutively express HA-tagged wild-type E4-ORF3 or a
nonfunctional mutant protein (N82A; (Evans and Hearing, 2005;
Stracker et al., 2002)). A rabbit polyclonal antibody directed against
TIF1γ was used for immunoprecipitation and coprecipitation of wild-
type or mutant E4-ORF3 was examined by Western blot using an anti-
HA antibody (Fig. 2). Equal levels of wild-type andmutant E4-ORF3 pro-
teins were evident in the starting cell extracts (lanes 1–3, bottom), but
only the wild-type E4-ORF 3 protein coprecipitated with endogenous
TIF1γ (lanes 4–6, bottom). Similar levels of TIF1γ were evident in the
starting cell extracts and immunoprecipitates, although we note some-
what reduced TIF1γ levels in wild-type Ad5-infected samples (top
panel). We conclude that the E4-ORF3 protein induces TIF1γ relocaliza-
tion in Ad-infected cells in vivo and that wild type E4-ORF3, but not a
nonfunctional mutant protein, binds TIF1γ in vitro.
E4-ORF3 targets the coiled-coil domain of TIF1α, TIF1β, and TIF1γ
Previously published results demonstrated that the RBCC domain
of TIF1α is necessary and sufﬁcient to mediate colocalization with
E4-ORF3 (Yondola and Hearing, 2007). To map the amino acid se-
quences required for interaction with E4-ORF3 to within a speciﬁc
TIF1α protein folding motif, we generated a series of recombinant
EYFP-TIF1α fusion proteins (Fig. 3) consisting of the RING ﬁnger do-
main (EYFP-αR), the B-box domain (EYFP-αBB), or the Coiled-Coil
domain (EYFP-αCC) fused to EYFP. Vectors that express these fusion
proteins were transfected into HeLa cells on coverslips, which were
then infectedwith wild-type Ad5 for 18 h, and then ﬁxed and immuno-
stained for the E4-ORF3 protein (Fig. 4). Expression of E4-ORF3 failed to
lead to the relocalization of EYFP-αRING or EYFP-αB-Box (data not
shown). When expressed in uninfected cells, EYFP-αCC displayed
both nuclear and cytoplasmic expression patterns (Fig. 4A). Nuclear lo-
calizing EYFP-αCCwas clearly brought into E4-ORF3-colocalizing tracks
following Ad infection (Figs. 4B–D), suggesting that the coiled-coil do-
main of TIF1α is sufﬁcient for E4-ORF3-induced relocalization.
As E4-ORF3 possesses the ability to target the Coiled-Coil domain of
TIF1α, we hypothesized that E4-ORF3 would also target the Coiled-Coil
domain of TIF1γ. Equivalent constructs consisting of the EYFP-tagged
Coiled-Coil domains of TIF1β (EYFP-βCC) and TIF1γ (EYFP-γCC) were
generated (Fig. 3). Vectors that express these fusion proteins were
Fig. 1. E4-ORF3 alters the localization of endogenous TIF1γ in vivo. A. Endogenous TIF1γ localization in mock-infected Hela cells was analyzed by indirect immunoﬂuorescence
using anti-TIF1γ primary antibody and FITC-conjugated secondary antibody. B. PML localization in the same cell using anti-PML primary antibody and TRITC-conjugated secondary
antibody. C. Merge of panels A and B; arrows indicate colocalization of TIF1γ and PML nuclear bodies. D–F. TIF1γ localization at early times after infection with wild-type Ad5 at a
multiplicity of infection of 200 virus particles/cell. D. TIF1γ localization performed described as in A. E. E4-ORF3 localization using an anti-E4-ORF3 primary antibody and TRITC-
conjugated secondary antibody. F. Merge of panels D and E. G. HeLa cells were infected with wild type Ad5 at a multiplicity of infection of 1000 virus particles/cell and analyzed
as in A. H–J. TIF1γ localization at early times after infection with an E4-ORF3 mutant virus at 200 virus particles/cell. H. TIF1γ localization performed as described in A. I. Ad DBP
localization using an anti-DBP primary antibody and TRITC-conjugated secondary antibody. J. Merge of panels H and I. K–M. TIF1γ localization at late times after infection with
wild-type Ad5 at 200 virus particles/cells performed as described in D–F.
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type Ad5. In uninfected cells, EYFP-βCC maintained a diffuse, nuclear
staining pattern (Fig. 4E) whereas EYFP-γCC could be detected diffusely
spread throughout the cell with prominent cytoplasmic staining
(Fig. 4I). At high levels of expression, EYFP-γCC displayed a tendency
to form aggregates, although this was not the case for EYFP-βCC. Inter-
estingly, E4-ORF3 expression led to the rearrangement of the Coiled-
Coil domains of both TIF1β and TIF1γ (Figs. 4F–H and J–L), although
cytoplasmic EYFP-γCC could still be detected.
Although the Coiled-Coil domain of TIF1β colocalized with the
E4-ORF3 protein in nuclear tracks, the corresponding full-length pro-
tein does not (Yondola and Hearing, 2007). As Coiled-Coil domains
oftenmediate protein–protein interactions, one possibility is that isola-
tion of this region of TIF1β permits track localization through an inter-
action with an endogenous Coiled-Coil-containing, track-associated
protein. To elucidate the potential for promiscuous track localization,
we generated an EYFP-tagged Coiled-Coil construct from PML (EYFP-
PML-CC; Fig. 3), a protein brought into E4-ORF3-containing tracks
through a region mapped outside of the Coiled-Coil motif (Leppard
et al., 2009). To minimize protein aggregation, we expressed this con-
struct in HeLa cells that were subsequently infected with wild-type
Ad5 for 8 h. The EYFP-PML-CC fusion protein remained diffuselylocalized throughout infected cells (Figs. 4N–P), displaying a similar lo-
calization pattern as that seen in uninfected cells (Fig. 4M). At higher
levels of expression, EYFP-PML-CC displayed a tendency to formmul-
tiple nuclear and cytoplasmic punctate aggregates. In some in-
stances, E4-ORF3 could be seen colocalizing with EYFP-PML-CC in
these punctate aggregates (data not shown). However, the high
level of expression required, altered appearance, and presence in
the cytoplasm differed greatly from the typical E4-ORF3 track local-
ization. As this atypical E4-ORF3 localization pattern was only seen
during instances of high levels of EYFP-PML-CC expression, it is likely
due to protein over-expression and possible protein aggregation,
rather than resulting from a direct E4-ORF3/EYFP-PML-CC interac-
tion. Together, these data support the idea that the E4-ORF3 protein
speciﬁcally interacts with the Coiled-Coil domains of TIF1 proteins.
Protein context inﬂuences the ability of E4-ORF3 to interact with TIF1
Coiled-Coil domains
One explanation for these results suggests that the E4-ORF3 pro-
tein may target a sequence found in all three TIF1 Coiled-Coil motifs
and that its isolation removes an interfering factor found within
full-length TIF1β. In order to examine the ability of the TIF1 Coiled-
Fig. 2. The wild-type, but not the N82A mutant, E4-ORF3 protein coimmunoprecipi-
tates with endogenous TIF1γ in vitro. HeLa cells were mock-infected (M) or infected
with Ad vectors that expressed either the wild-type (WT) or the N82A (N82A) mutant
HA-tagged E4-ORF3 proteins. Immunoprecipitations from whole cell extracts (WCE)
were performed using anti-TIF1γ antibody, and Western blots were probed using anti-
bodies against TIF1γ (top panel) and HA (bottom panel). Lanes 1–3 show proteins pre-
sent in the starting WCE. Lanes 4–6 show proteins immunoprecipitated with the anti-
TIF1γ antibody.
320 E.I. Vink et al. / Virology 422 (2012) 317–325Coil domains to interact with E4-ORF3 in the context of full-length
TIF1 proteins, we generated a series of EYFP-tagged protein chimeras
consisting of TIF1β containing the Coiled-Coil domain of TIF1α or
TIF1γ (EYFP-TIF1β-αCC, EYFP-TIF1β-γCC; Fig. 3) and TIF1α contain-
ing the Coiled-Coil domain of TIF1β (EYFP-TIF1α-βCC; Fig. 3). All
three fusion proteins displayed a diffuse, nuclear staining pattern in
uninfected cells (Figs. 5A, E, and I). Following infection with wild-
type Ad5, E4-ORF3 rearranged EYFP-TIF1α-βCC into E4-ORF3-
colocalizing nuclear tracks (Figs. 5B–D). EYFP-TIF1β-αCC and EYFP-
TIF1β-γCC retained a diffuse nuclear localization pattern in cells
infected with wild-type Ad5 (Figs. 5F–H and J–L). The ability of all
three Coiled-Coil motifs to direct the localization in the context of
TIF1α or TIF1γ, but not TIF1β, suggests that additional sequences pre-
sent in full-length TIF1β inhibits an intrinsic association ability with
the E4-ORF3 protein.Fig. 3. Diagramof the EYFP-TIF1 fusion proteins described in the text. Abbreviations are: R,
Ring ﬁnger domain; BB, B Box domain; CC, Coiled-Coil domain; CTH, C-terminal half; α,
TIF1α coding sequences; β, TIF1β coding sequences; γ, TIF1γ coding sequences.The C-terminal half of TIF1β interferes with the ability of E4-ORF3 to tar-
get the TIF1β Coiled-Coil domain
If a portion of TIF1β interferes with the ability of E4-ORF3 to inter-
act with the Coiled-Coil domain, its removal should facilitate E4-
ORF3-induced track localization. As TIF1α, TIF1β, and TIF1γ share a
homologous N-terminal RBCC domain, we wished to determine if
the removal of the C-terminal half (CTH) of TIF1β, consisting of the
divergent middle region and a conserved PHD/Bromo domain, per-
mitted E4-ORF3-mediated relocalization. The RBCC domain of TIF1β
was fused to EYFP (EYFP-βRBCC; Fig. 3) and the expression vector
was transfected into HeLa cells. In uninfected cells, EYFP-TIF1β dis-
played a diffuse, nuclear staining pattern whereas EYFP-βRBCC was
seen diffusely spread throughout the cell (Figs. 6A and E). Eighteen
hours after infection with wild-type Ad5, EYFP-TIF1β retained a diffuse
nuclear staining pattern, however, EYFP-βRBCC associated with E4-
ORF3 in nuclear tracks (Figs. 6B–D and F–H). To further demonstrate
the ability of the CTHof TIF1β to interferewith E4-ORF3-induced reloca-
lization, we generated an EYFP fusion protein consisting of the RBCC
domain of TIF1α fused to the CTH of TIF1β (EYFP-TIF1α-βCTH; Fig. 3).
We previously demonstrated that the EYFP-αRBCC was relocalized
into nuclear tracks following E4-ORF3 expression (Yondola and
Hearing, 2007). In contrast, EYFP-TIF1α-βCTH failed to colocalize with
E4-ORF3 maintaining a diffuse, nuclear staining pattern similar to that
seen in uninfected cells (Figs. 6I–L). This result indicates that the pres-
ence of the CTH of TIF1β interferes with the ability of E4-ORF3 to target
the Coiled-Coil domain of TIF1α. Together, these results suggest that
the CTH of TIF1β interferes with the ability of E4-ORF3 to access the
Coiled-Coil motif of TIF1β.
We veriﬁed these results using a coimmunoprecipitation assay.
Different EYFP-TIF1 fusion proteins were expressed in transfected
HeLa cells and cells were thenmock-infected or infected with a recom-
binant Ad vector that expresses wild-type, HA-tagged E4-ORF3 protein.
EYFP-TIF1 proteins were immunoprecipitated from cell extracts using
an anti-GFP antibody that recognizes EYFP. Binding of HA-E4-ORF3
was assessed by Western blot analysis using an anti-HA antibody
(Fig. 7).While the levels of the EYFP-TIF1 fusion proteins immunopreci-
pitated varied between constructs, EYFP-TIF1α and EYFP-TIF1γ, but not
EYFP-TIF1β, coprecipitated with HA-E4-ORF3. In agreement with the
immunoﬂuorescence results, EYFP-TIF1α-βCC bound HA-E4-ORF3,
whereas neither EYFP-TIF1β-αCC nor EYFP-TIF1β-γCC did despite
high levels of immunoprecipitated proteins in these samples. In further
support, the EYFP-TIF1α-βCTH fusion protein did not detectably copre-
cipitatewithHA-E4-ORF3. These results verify the immunoﬂuorescence
assays and conﬁrm that E4-ORF3-induced TIF1 relocalization into nu-
clear tracks requires speciﬁc interactions between these cellular and
viral proteins.
Discussion
In this study, we demonstrate that the Ad5 E4-ORF3 protein binds
to endogenous TIF1γ in vitro and relocalizes endogenous TIF1γ into
E4-ORF3-containing tracks in vivo. Further, we show that the
Coiled-Coil domain is the only isolated TIF1α segment brought into
nuclear tracks; the RING, B box, and C-terminal half of TIF1α–consist-
ing of the middle region, PHD, and Bromo domain–fail to colocalize
with E4-ORF3 when expressed individually as EYFP fusion proteins
(this study, and Yondola and Hearing, 2007). In addition, E4-ORF3
holds the ability to rearrange the isolated Coiled-Coil domains of
TIF1β and TIF1γ. However, Coiled-Coil domains expressed in the con-
text of full-length TIF1β (EYFP-TIF1β-αCC and EYFP-TIF1β-γCC) as
well as TIF1β, fail to colocalize with E4-ORF3 in nuclear tracks.
These data suggest that the E4-ORF3 protein does not simply target
a consensus sequence found in TIF1α and TIF1γ but absent from
TIF1β. The ability of TIF1 Coiled-Coil domains to permit track localiza-
tion in isolation or in the context of TIF1α, but not in the context of
Fig. 4. E4-ORF3 rearrangement of the Coiled-Coil domains isolated from TRIM family proteins. HeLa cells were transfected with expression vectors encoding EYFP-tagged Coiled-
Coil domains from TIF1α (A–D), TIF1β (E–H), TIF1γ (I–L), or PML (M–P), then mock-infected (A, E, I, and M) or infected with wild-type Ad5 (F–H, J–L, N–P). At 18 h post-infection
(A–L) or 8 h post-infection (M–P), cells were ﬁxed and stained with an antibody directed against E4-ORF3 followed by a TRITC labeled secondary antibody (C, G, K, O). EYFP fusion
protein localization is shown in B, F, J, and N. EYFP:E4-ORF3 merged images are shown in D, H, L, and P.
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of E4-ORF3 to interact with this TIF1 protein. We acknowledge that
tagging the different proteinswith EYFP at their N-terminimay inﬂuence
their behavior, but collectively all of the data are consistentwith the con-
clusion that E4-ORF3 targets the Coiled-Coil domains of TIF1 proteins for
relocalization.
As Coiled-Coil domains often mediate protein–protein interac-
tions, it is possible that these EYFP-TIF1 fusion proteins might gain
the ability to interact with a track-localizing protein that contains a
Coiled-Coil motif, such as PML or endogenous TIF1α, and are reloca-
lized by E4-ORF3 in an indirect manner. However, the absence of relo-
calization of EYFP-PML-CC following E4-ORF3 expression detracts
from this hypothesis. Our results indicate that the Coiled-Coil do-
mains from all three tested TIF1 family proteins contain a sequence
that is a target for E4-ORF3-induced relocalization. Since the addition
of the βCTH to the RBCC domain of TIF1α disrupts track localization,
our results suggest that the βCTH actively interferes with E4-ORF3
relocalization of the full-length TIF1β protein. The nature of this inter-
ference, however, remains unknown. In addition to a conserved PHD/
bromo domain, the βCTH contains themiddle region—a segment of low
sequence conservation between TIF1α, TIF1β, and TIF1γ (Venturini
et al., 1999). It is possible that a sequence unique to TIF1β generates a
protein folding conformation that physically blocks the ability of E4-
ORF3 to associate with the TIF1β Coiled-Coil domain. A recent publica-
tion characterizes potential synergistic activities between TIF1α, TIF1β,and TIF1γ in the context of murine hepatocellular carcinoma develop-
ment and demonstrates the presence of a TIF1α- and TIF1γ-containing
protein complex as well as a less abundant TIF1α-, TIF1β-, and TIF1γ-
containing complex (Herquel et al., 2011). It is interesting to speculate
that the same properties that facilitate the formation of these com-
plexes play a role in permitting or disallowing E4-ORF3-mediated
track localization.
Recent work suggests that E4-ORF3 relocalizes PML through a di-
rect interaction with a short amino acid sequence unique to PML iso-
form II-speciﬁc exon 7b (Hoppe et al., 2006; Leppard et al., 2009). An
alignment of this region, spanning PMLII amino acids 645–684, with
other known E4-ORF3-associated proteins including TIF1α, revealed
a short, loosely homologous sequence motif. In agreement with our
data, this short sequence can be found within the Coiled-Coil do-
mains of TIF1α (residues 375–391), TIF1β (residues 361–377), and
TIF1γ (residues 427–443). Interestingly, the E4-ORF3-interacting re-
gion in PMLII exon 7b falls outside the PML N-terminal RBCC motif,
indicating that the Coiled-Coil domain of PML is neither necessary
nor sufﬁcient for E4-ORF3-induced relocalization. Furthermore, the
ability of E4-ORF3 to target the Coiled-Coil domain of TIF1β outside
of the context of the wild-type protein suggests that protein context,
in addition to the presence of a speciﬁc target sequence, plays a role
in E4-ORF3-mediated protein relocalizaiton.
Whereas much is known about the roles TIF1α and TIF1γ play
under normal cellular conditions, the functional signiﬁcance of their
Fig. 5. E4-ORF3 interaction with the TIF1 Coiled-Coil domain in different protein con-
texts. HeLa cells were transfected with expression vectors containing EYFP fused to
TIF1α containing the Coiled-Coil domain of TIF1β (A–D), or TIF1β containing the
Coiled-Coil domain of TIF1α (E–H) or TIF1γ (I–L). Cells were mock-infected (A, E, I)
or infected with wild-type Ad5 (B–D, F–H, J–L). Eighteen hours later, the cells were
ﬁxed and stained with an antibody directed against E4-ORF3 followed by a TRITC labeled
secondary antibody (C, G, K). EYFP fusionprotein localization is shown inA–B, E–F, and I–J.
EYFP:E4-ORF3 merged images are shown in D, H, and L.
Fig. 6. The C-terminal half of TIF1β interferes with E4-ORF3-directed TIF1 relocalization.
Hela cells were transfected with expression vectors containing EYFP-TIF1β (A–D), EYFP-
βRBCC (E–H), or EYFP-TIF1α-βCTH (I–J). Cells were mock-infected (A, E, I) or infected
with wild-type Ad5 (B–D, F–G, J–L). Eighteen hours later, the cells were ﬁxed and stained
with an antibody directed against E4-ORF3 followed by a TRITC labeled secondary anti-
body (C, G, K). EYFP fusion protein localization is shown in A–B, E–F, and I–J. EYFP:E4-
ORF3 merged images are shown in D, H, and L.
Fig. 7. Interaction EYFP-TIF1 fusion proteins with wild-type E4-ORF3 in vitro. HeLa cells
were transfected with expression vectors containing EYFP-TIF1 fusion proteins indi-
cated across the top (see Fig. 3 for depictions) and subsequently mock-infected
(Mock, bottom) or infected with an Ad vector expressing HA-tagged wild-type
E4-ORF3 protein (+HA-ORF3-WT, bottom). Proteins in cell extracts were immunopreci-
pitated using an EGFP antibody that cross-reacted with the EYFP and then subjected to
Western blot analysis using anti-HA (top panel) and anti-GFP (bottom panel) antibodies.
322 E.I. Vink et al. / Virology 422 (2012) 317–325relocalization during Ad infection remains unclear. The rearrange-
ment of other known E4-ORF3 targets (e.g., PML and MRN), serves
to inhibit their anti-viral activities. Rearrangement by E4-ORF3
could function as a mechanism to target a cellular process dependent
on these two proteins. Acting as transcriptional coregulators, TIF1α
inﬂuences the retinoic acid signaling pathway while TIF1γ affects
TGFβ-dependent signaling as well as transcriptional elongation (Bai
et al., 2010; Dupont et al., 2009; He et al., 2006; Khetchoumian
et al., 2007). It is possible that E4-ORF3 sequesters TIF1α and TIF1γ
to alter their downstream transcriptional target levels. TIF1α and
TIF1γ also have both been shown to contain E3 ubiquitin ligase activ-
ities in certain contexts (Allton et al., 2009; Dupont et al., 2005, 2009).
Recruitment into nuclear tracks could serve to regulate ubiquitin li-
gase activity, either by preventing TIF1α and TIF1γ from promoting
the ubiquitination of target proteins or by promoting the ubiquitina-
tion of one or more track-associated proteins. The E4-ORF3 protein
previously was shown to facilitate MRN protein degradation in Ad-
infected cells (Liu et al., 2005). Finally, E4-ORF3-dependent rearran-
gement of TIF1 proteins could provide an additional way for Ad to in-
ﬂuence cell proliferation. Whereas Ad targets terminally differentially
epithelial cells for infection, it has evolved multiple mechanisms to
force the cell to return to S-phase, generating a cellular environment
more conducive to productive virus replication (reviewed in Berk,
2005). Over-expression of either TIF1α or TIF1γ has been shown toretard cell growth and these proteins have been linked as tumor sup-
pressors in murine and human cancer (Khetchoumian et al., 2007;
Vincent et al., 2009). E4-ORF3 may inﬂuence cellular growth by
323E.I. Vink et al. / Virology 422 (2012) 317–325inhibiting the roles of these TIF1 proteins as negative regulators of
cellular proliferation.
The E4-ORF3-dependent reorganization of TIF1α and TIF1γ is an
attractive target for future studies asmanyTRIM family proteins possess
functions that participate in the cellular innate immune response; as
many as 27 display altered expression patterns in the presence of inter-
feron (Carthagena et al., 2009). Several TRIM proteins have been impli-
cated as effectors in the IRF3/IRF7- and NF-κB-dependent signaling
pathways, modifying interferon and proinﬂammatory cytokine produc-
tion, respectively (Ozato et al., 2008). For example, TRIM25 induces ubi-
quitination of cytosolic RNA sensor RIG-I, which ultimately promotes
downstream IFN-β expression (Gack et al., 2007). Also known as RFP,
TRIM27 binds to protein kinases TBK1, IKKα, IKKβ, and IKKεwhich pro-
motes the inhibition of IRF3- andNF-κB-dependent signaling (Zha et al.,
2006). PML, TRIM19, is implicated in the restriction ofmultiple DNA and
RNA virus replication cycles (reviewed in Everett and Chelbi-Alix,
2007). Other TRIM family proteins function to restrict virus propagation
directly. TRIM22 expression is correlated with a decrease in HIV-1 long
terminal repeat driven gene expression (Kajaste-Rudnitski et al., 2011)
and has been shown to inhibit HIV particle production by interfering
with the localization of structural protein gag and virus particle release
(Barr et al., 2008). Implicated as a factor that can restrict HIV infection,
rhesus monkey TRIM5α (TRIM5αrh) has been shown to promote pre-
mature capsid uncoating as well as facilitate gag protein degradation
(Sakuma et al., 2007; Stremlau et al., 2006). TIF1α and TIF1γ may
possess similar anti-viral activities, but additional studies are needed
to address this possibility.Materials and methods
Plasmid construction
EYFP fusion proteins were generated using pEYFP-C1 (Clontech).
Primer pairs used for fusion protein cloning are shown in Table 1.
TIF1α and TIF1β cDNA clones were purchased from OriGene Technol-
ogies (Rockville, MD). A TIF1γ cDNA clone was provided by Dr. Joan
Massagué (Memorial Sloan Kettering Cancer Center, New York, NY).
EYFP-αRING (primer set 1), EYFP-αBbox, (primer set 2), EYFP-αCC
(primer set 3), EYFP-βCC (primer set 4), EYFP-γCC (primer set 5),
EYFP-PML-CC (primer set 11), and EYFP-βRBCC (primer set 12) were
generated using polymerase chain reaction (PCR)-directed ampliﬁca-
tion of TIF1- or PML-speciﬁc protein coding sequences. Amplicons
were cut with BglII and XmaI restriction endonucleases and incorporat-
ed into pEYFP-C1 cutwith the same enzymes. EYFP-βRBCCwas cutwith
BglII and BamHI before incorporation into pEYFP-C1. EYFP-TIF1β-αRB
was generated through the PCR-directed ampliﬁcation of the Coiled-
Coil and CTH of TIF1β (primer set 8), digestion with HindIII and BglII,
and ligation into an EYFP-TIF1α vector digested with BamHI and HindIII.Table 1
Primer pairs used for PCR.
Primer Set Construct 5′ primer
1 EYFP-αRING GGATCCAGATCTATGGAGGTGGCGGTG
2 EYFP-αBbox GGATCCAGATCTGACACTACTGAGGTTCC
3 EYFP-αCC GGATCCAGATCTCAATTTATAGAAGAAGCTTTT
4 EYFP-βCC GGATCCAGATCTCAGTTCTTAGAGGATGC
5 EYFP-γCC GGATCCAGATCTCAGTTTTTGGAAGAAGCT
6 EYFP-TIF1α-βCC GGAAGATCTATCCCCAGTGACCAAC
7 EYFP-TIF1β-αRBCC A: GGAAGATCTATGGAGGTGGCGGTG; B:
ACCTCCTTAAGATGATTGTGGATCCC
8 EYFP-TIF1β-αRB GCAAGCTTTTAGGAACCAGCGCAAG
9 EYFP-TIF1β-αCC GGACTCAGATCTCGAG
10 EYFP-TIF1β-γCC TTTTGGAAGAAGCTTTTC
11 EYFP-PMLCC GGAAGATCTTGCGACATCAGCGCA
12 EYFP-βRBCC GGACTCAGATCTCGAGEYFP-TIF1β-αRBCC was generated through the PCR directed ampliﬁca-
tion of αRBCC (primer set 7a) and βCTH (primer set 7b), ligation via
PCR, and insertion into the pEYFP-C1 vector. EYFP-TIF1α-βCCwas gener-
ated through the PCR-directed ampliﬁcation of αCTH (primer set 6), di-
gestion with BglII and XbaI, and insertion into EYFP-TIF1β-αRB cleaved
with BamHI and XbaI. EYFP-TIF1β-αCC was generated through the
PCR-directed ampliﬁcation of βRB (primer set 9), cleavage with BglII
and HindIII, and insertion into EYFP-TIF1β-αRBCC digested with BglII
and HindIII. EYFP-TIF1β-γCC was generated through the PCR-directed
ampliﬁcation of γCC (primer set 10). The PCR amplicon and EYFP-
TIF1β-αCC vector were then digestedwithHindIII and BamHI and ligat-
ed together.
Cell culture, transfection, and virus infections
Experiments were carried out in HeLa cells (ATCC) grown in
Dulbecco's modiﬁed eagle medium supplemented with 10% bovine
calf serum, unless otherwise speciﬁed. Cells were transfected using
Fugene 6 (Roche) or polyethylenimine (PEI) (Polysciences Inc.) via
the manufacturer's instruction. Proteins were allowed to express over-
night, and cells were subsequently infected with virus, when indicated.
Cells were infected with wild-type Ad5 at 200 virus particles/cell or
with Ad E1-replacement viruses that express HA-tagged wild-type or
mutant E4-ORF3 at 500 virus particles/cell for 1 h before the addition
of new media. The following viruses were used: phenotypically wild-
type Ad5 dl309 (Jones and Shenk, 1979), and Ad-CMV-HA-PORF3-WT
or -HA-ORF3-N82A (E1A replacement viruses that expresses E4-ORF3
fused to an HA epitope under the control of a CMV promoter (Evans
and Hearing, 2003, 2005).
Immunoﬂuoresence analysis
Cells were grown on glass coverslips, transfected, and then infected
using the conditions described above. Between 16 and 18 h post-
infection, cells were washed with PBS, ﬁxed using −20 °C methanol,
and blocked for 1 h at room temperature with 10% goat serum diluted
into PBS. Primary antibody consisting of either rat monoclonal anti-
E4-ORF3 (mAb 6A11 (Nevels et al., 1999)), rabbit polyclonal anti-
TIF1γ (generated at Lampire Biological Laboratories, Pipersville, PA),
or anti-PML (PG-M3, Santa Cruz Biotechnology) diluted into 10% goat
serumblockwas applied to coverslips for 1 h at room temperature. Cov-
erslips were then washed with PBS and incubated with secondary anti-
body consisting of tetramethyl rhodamine isothiocyanate (TRITC)
labeled anti-rat (Invitrogen), or ﬂuorescein isothiocyanate (FITC) la-
beled anti-rabbit (Invitrogen) for 30 min at room temperature in the
dark. Coverslipsweremounted on slides using ImmunoMount (Thermo
Shandon). The microscope used was a Zeiss Axiovert 200M Digital
Deconvolution Microscope ﬁtted with a Chroma ﬁlter set and an3′ primer Restriction
enzymes
GGATCGCCCGGGTTAGTTCACAAAAAAGTTATCTA BglII, XmaI
GGATCCCCCGGGTTAGTATCTATGCTCTTTATGTT BglII, XmaI
GGATCCCCCGGGTTACCTTGCACGAAGGAGG BglII, XmaI
GGATCCCCCGGGTTAAATCATCTTGAGGGCC BglII, XmaI
GGATCCCCCGGGTTACCGTGCTTTCAAAATATG BglII, XmaI
GGATCCTCTAGATTATTTAAGCAACTGGCGTT BglII, BamHI, XbaI
A: CAATCATCTTAAGGAGGTGCCGTAA; B:
GGAAGATCTTCAGGGGCCATCACC
BglII
GGAAGATCTTCAGGGGCCATCACC BglII, BamHI, HindIII
GGATCCAAGCTTCCTCTAAGAACTGGTAC BglII, HindIII
CGCGGATCCCACCGTGCTTTCAAAAT HindIII, BamHI
GGATCCCCCGGGTTACTCCTGGCGCAGGC BglII, XmaI
GGATCCGAATTCTTAAATCATCTTGAGGGCC BglII, BamHI
324 E.I. Vink et al. / Virology 422 (2012) 317–325apotome and images were captured with a Peltier-cooled CCD Axiocam
HRm camera and analyzed with Axiovision 4.5 software.
Immunoprecipitation and western blot analysis
Ten centimeter dishes of HeLa cells were transfected with 5 μg of
each EYFP expression vector indicated and infected with Ad-CMV-HA-
ORF3-WT, as described above. At 18 h post-infection, cells werewashed
with PBS, collected, and resuspended in F-lysis buffer (50 mM Tris pH
7.4, 50 mM NaCl, 10% glycerol, 0.5% Triton X-100) supplemented with
protease inhibitors (phenylmethylsulfonyl ﬂuoride, benzamidine, pep-
statin, leupeptin, and aprotinin). The cellular lysate was incubateded
on ice for 20 min, sonicated at 50% duty, setting 5, for 20 pulses on ice,
and then centrifuged for 15 min, 16000×g, at 4 °C. Protein A beads
were used to preclear the soluble lysate during a 1 hour rotation at
4 °C. The samples were cleared by centrifugation, the lysate was incu-
bated with rabbit anti-GFP (Lifespan Biosciences) and protein A beads
with rotation overnight at 4 °C. The immunoprecipitates were then
washed ﬁve times with F-lysis buffer containing protease inhibitors
and resuspended in 40 μl 2X Laemmli sample buffer (1.2% SDS,
150 mM Tris pH 6.8, 50 mM dithiothreitol). Samples were incubated
at 95 °C for 5 min and subjected to SDS-PAGE. An 18.5% gel was used
to resolve HA-ORF3 whereas a 7.5% gel was used to resolve the EYFP-
tagged fusion proteins. Proteins were transferred to polyvinylidene
ﬂuoride (PVDF) (Hybond-P, GE Healthcare) membranes overnight at
40 mA. PVDF membranes were blocked for 1 h with 3% BSA in PBS,
then incubated with primary antibody, consisting of either mouse
monoclonal anti-HA (Abcam) or anti-GFP rabbit polyclonal antibody
(Lifespan Biosciences), overnight at 4 °C. The membranes were washed
and anti-mouse HRP and anti-rabbit HRP (GE Healthcare) secondary
antibodieswere applied tomembranes for 30 min. Immobilon chemilu-
minescent HRP substrate (Millipore) was used for detection.
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